M20 Genomics, a life science company, develops and applies single-cell technology. It aims to be a global leader in disease diagnosis and treatment through next-generation single-cell sequencing technology. Its VITA series products can break through to achieve high-throughput single-cell sequencing of all sample types (formalin-fixed, paraffin-embedded (FFPE), frozen and fresh samples), all species (eukaryotes and prokaryotes), and full-length transcriptome sequencing.